Promore Pharma
Promore Pharma: Raising capital at a deep discount (Redeye)

2019-10-07 08:55
The announcement of a rights issue (guaranteed up to 80 percent) was no big surprise. The surprise was instead the insufficient size of capital being raised (~SEK 75m), the very deep discount of the issue price (~70% compared to the previous closing), and high transaction costs (16-20% depending on subscription amount). Taking all this into account, we lower our base case value.

info@redeye.se (Redeye.se)
Redeye AB - Redeye.se

PMD Device Solutions - I dag

{point.key}

Marknadsöversikt

Stockholmsbörsen, OMXS30

I dag
-
Senast
-
{point.key}

Världsindex

Index +/- % Senast
DAX - -
Hang Seng - -
Nikkei - -

Valutor

Valuta +/- % Senast
USD/SEK - -
EUR/SEK - -
GBP/SEK - -
EUR/USD - -

Räntor

Ränta +/- % Senast
5-års ränta - -
10-års ränta - -

Råvaror

Råvara +/- % Senast
Guld - -
Silver - -
Koppar - -